drugset / Trial / NCT02200237
A Clinical Study for Inactivated Vaccine Against EV71
RandomizedParallel-groupQuadruple-blindPrevention
Summary
This study aims to evaluate the safety, reactogenicity and immunogenicity of EV71 vaccine in health children and infants aged from 2 months to \<12yrs.
Timeline
- Start
- 2014-09
- Primary completion
- 2017-05
- Completion
- 2017-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | EV71 vaccine | Vaccine | 150 ug | — |